NCT03947866View on ClinicalTrials.gov

Ezetimibe-Rosuvastatin Evaluation Study

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
HypercholesterolemiaHyperlipidemiasCombinations of Drugs; Dependence
Trial Locations (1)

Unknown

RECRUITING

Athens University Hospital HIPPOKRATEION, Athens

Sponsors
All Listed Sponsors
lead

Elpen Pharmaceutical Co. Inc.

INDUSTRY